siRNA FOXO1

siRNA / miRNA gene silencing Human - CRL-5915 FOXO1

Experiment
siRNA / miRNA gene silencing Human - CRL-5915 FOXO1
Product
siRNA FOXO1 from Thermo Fisher Scientific
Manufacturer
Thermo Fisher Scientific

Protocol tips

Protocol tips
Add diluted siRNA to diluted Lipofectamine® RNAiMAX Reagent (1:1 ratio).

Incubate for 5 minutes at room temperature and add to cells.

Incubate cells for 1–3 days at 37°C

Publication protocol

Cells at 60 to 80% confluence were co-transfected with miRNA inhibitors (miR-182 inhibitor, miR-183 inhibitor, both miR-182 and miR-183 inhibitors, or negative control miRNA inhibitor) along with Silencer select siRNA (FOXO1 (assay id #s5257 and #s5258) or negative control siRNA #1 (Thermo Fisher Scientific) using Lipofectamine RNAiMAX according to the manufacturer's protocols.

Full paper   Login or join for free to view the full paper.

Reviews

siRNA FOXO1 from Thermo Fisher Scientific has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Human - CRL-5915 FOXO1 using siRNA FOXO1 from Thermo Fisher Scientific.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Thermo Fisher Scientific for siRNA FOXO1 below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - CRL-5915 FOXO1 using siRNA FOXO1 from Thermo Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms